EH
Elaine Hamm
No background info available
Check back soon. More details may be added later.
Partnering listings
Learn more
Ascendis Pharma
Epigenome therapy for SNCA modulation in parkinson's disease
A targeted epigenetic approach to downregulate SNCA expression in dopaminergic neurons, aiming to reduce α-synuclein pathology and neurodegeneration in Parkinson's Disease. This method seeks to maintain physiological SNC...
TechnologyConceptualCompany
Ascendis Pharma
Targeted apoee4 gene therapy for alzheimer's disease treatment
A novel gene therapy targeting APOEe4 expression aims to reduce amyloid-β pathology, decrease neuroinflammation, and slow cognitive decline in Alzheimer's patients without detrimental effects of complete APOE elimination...
TechnologyConceptualCompany
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.